Jonathan P. Foster is Chief Financial Officer of Moleculin Biotech, Inc.. Currently has a direct ownership of 287,587 shares of MBRX, which is worth approximately $89,151. The most recent transaction as insider was on Jun 23, 2025, when has been sold 270,270 shares (Common Stock) at a price of $0.37 per share, resulting in proceeds of $99,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 288K
2430.91% 3M change
2430.91% 12M change
Total Value Held $89,151

Jonathan P. Foster Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2025
BUY
Open market or private purchase
$99,999 $0.37 p/Share
270,270 Added 48.45%
287,587 Common Stock
Jun 22 2025
SELL
Payment of exercise price or tax liability
$284 $0.27 p/Share
1,054 Reduced 5.74%
17,317 Common Stock
Jun 22 2025
BUY
Exercise of conversion of derivative security
-
4,328 Added 19.07%
18,371 Common Stock
Jun 20 2025
SELL
Payment of exercise price or tax liability
$178 $0.27 p/Share
661 Reduced 4.5%
14,043 Common Stock
Jun 20 2025
BUY
Exercise of conversion of derivative security
-
2,711 Added 15.57%
14,704 Common Stock
Jun 16 2025
SELL
Payment of exercise price or tax liability
$140 $0.69 p/Share
203 Reduced 1.66%
11,993 Common Stock
Jun 16 2025
BUY
Exercise of conversion of derivative security
-
833 Added 6.39%
12,196 Common Stock
Jun 22 2024
SELL
Payment of exercise price or tax liability
$3,938 $3.74 p/Share
1,053 Reduced 8.48%
11,363 Common Stock
Jun 22 2024
BUY
Exercise of conversion of derivative security
-
4,329 Added 25.85%
12,416 Common Stock
Jun 20 2024
SELL
Payment of exercise price or tax liability
$2,404 $3.78 p/Share
636 Reduced 7.29%
8,087 Common Stock
Jun 20 2024
BUY
Exercise of conversion of derivative security
-
2,712 Added 23.72%
8,723 Common Stock
Jun 16 2024
SELL
Payment of exercise price or tax liability
$811 $4.14 p/Share
196 Reduced 3.16%
6,011 Common Stock
Jun 16 2024
BUY
Exercise of conversion of derivative security
-
834 Added 11.84%
6,207 Common Stock
Dec 26 2023
BUY
Open market or private purchase
$20,000 $0.69 p/Share
28,986 Added 26.46%
80,556 Common Stock
Jun 20 2023
SELL
Payment of exercise price or tax liability
$5,515 $0.57 p/Share
9,676 Reduced 15.8%
51,570 Common Stock
Jun 20 2023
BUY
Exercise of conversion of derivative security
-
40,667 Added 39.9%
61,246 Common Stock
Jun 16 2023
SELL
Payment of exercise price or tax liability
$1,735 $0.57 p/Share
3,044 Reduced 12.89%
20,579 Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
-
12,500 Added 34.6%
23,623 Common Stock
Jun 16 2022
SELL
Payment of exercise price or tax liability
$4,049 $1.33 p/Share
3,044 Reduced 21.49%
11,123 Common Stock
Jun 16 2022
BUY
Exercise of conversion of derivative security
-
12,500 Added 46.87%
14,167 Common Stock

Also insider at

VLCN
Volcon, Inc. Consumer Cyclical
JPF

Jonathan P. Foster

Chief Financial Officer
Round Rock, TX

Track Institutional and Insider Activities on MBRX

Follow Moleculin Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MBRX shares.

Notify only if

Insider Trading

Get notified when an Moleculin Biotech, Inc. insider buys or sells MBRX shares.

Notify only if

News

Receive news related to Moleculin Biotech, Inc.

Track Activities on MBRX